Merck & Co., Inc: all 2,453 studies
Page 17 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)CompletedNCT06903715Phase 1
- A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)CompletedNCT06894771Phase 1
- A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)CompletedNCT06893081Phase 1
- A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)Active, not recruitingNCT06891066Phase 2
- A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035)CompletedNCT06880874Phase 1
- A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)Active, not recruitingNCT06864169Phase 2
- A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)CompletedNCT06860243Phase 1
- Single-Ascending Dose Study of MK-2060 in Healthy Chinese Male Adult Participants (MK-2060-009)CompletedNCT06843993Phase 1
- A Clinical Study of MK-7962 in Healthy Chinese Participants (MK-7962-021)CompletedNCT06843460Phase 1
- A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)CompletedNCT06836037Phase 1
- Activity Tracking Study in Healthy Volunteers (MK-0000-419)CompletedNCT06833879Phase 1
- Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)CompletedNCT06829225Phase 1
- A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)WithdrawnNCT06829199Phase 2
- A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)CompletedNCT06826989Phase 1
- A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)CompletedNCT06821334Phase 1
- A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)CompletedNCT06818968Phase 1
- A Study of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) and MK-8527 in Healthy ParticipantsCompletedNCT06816043Phase 1
- A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009)CompletedNCT06816030Phase 1
- Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)Active, not recruitingNCT06814145Phase 2
- A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)CompletedNCT06814132Phase 1
- A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)CompletedNCT06814119Phase 1
- A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)CompletedNCT06814106Phase 1
- A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058)CompletedNCT06811246Phase 1
- A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420)CompletedNCT06809569Phase 1
- A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)CompletedNCT06797674Phase 1
- Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)Active, not recruitingNCT06788912Phase 2
- A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)CompletedNCT06783192Phase 1
- A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)Active, not recruitingNCT06780085Phase 2
- A Clinical Study To Understand How Radiolabeled MK-5475 Is Taken Up By The Body, Broken Down And Then Removed From The Body in Healthy Participants (MK-5475-011)CompletedNCT06777602Phase 1
- A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-017)CompletedNCT06772818Phase 1
- A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-016)CompletedNCT06772805Phase 1
- A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)CompletedNCT06772792Phase 1
- A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)CompletedNCT06772779Phase 1
- A Study to Evaluate Oral Formulations of Tedizolid Phosphate in Healthy Participants (MK-1986-043)CompletedNCT06733688Phase 1
- A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)TerminatedNCT06721156Phase 2
- A Study of Doravirine and Islatravir as a Single Entity or Combination Therapy and the Effect of Food in Healthy Adult Participants (MK-8591A-055)CompletedNCT06719570Phase 1
- A Study of the Effect of Itraconazole and Phenytoin on Calderasib (MK-1084) in Healthy Adults (MK-1084-008)CompletedNCT06719557Phase 1
- A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)CompletedNCT06719544Phase 1
- A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)CompletedNCT06703463Phase 1
- A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)CompletedNCT06701305Phase 1
- A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)CompletedNCT06699355Phase 1
- A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)CompletedNCT06699329Phase 1
- A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)Active, not recruitingNCT06698042Phase 3
- A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)CompletedNCT06698016Phase 1
- A Clinical Study of MK-4318 and Diltiazem in Healthy People (MK-4318-003)CompletedNCT06692647Phase 1
- A Clinical Study of Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-025)CompletedNCT06691906Phase 1
- A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)Active, not recruitingNCT06688058Phase 1
- A Study of the Effects of Itraconazole on the Plasma Levels of Nemtabrutinib (MK-1026-013)CompletedNCT06688045Phase 1
- A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)CompletedNCT06687759Phase 1
- A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)CompletedNCT06665230Phase 1
- A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)CompletedNCT06664801Phase 2
- A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular DegenerationCompletedNCT06664502Phase 1/2
- A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)CompletedNCT06662396Phase 1
- The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022)CompletedNCT06658652Phase 1
- A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)CompletedNCT06658626Phase 1
- A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)CompletedNCT06655311Phase 1
- MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013)CompletedNCT06649877Phase 1
- A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005)CompletedNCT06647628Phase 1
- A Study of MK-2225 in Healthy Participants (MK-2225-003)CompletedNCT06643390Phase 1
- A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)CompletedNCT06637423Phase 1/2
- A Drug-Drug Interaction Study of Carbamazepine and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-012)CompletedNCT06633419Phase 1
- A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001)CompletedNCT06630117Phase 1
- A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)CompletedNCT06626464Phase 1
- A Study of MK-1167 in Healthy Elderly Participants (MK-1167-004)CompletedNCT06625840Phase 1
- A Study of the Effect of Nemtabrutinib (MK-1026) on the Plasma Levels of Digoxin in Healthy Participants (MK-1026-012)CompletedNCT06625827Phase 1
- A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)CompletedNCT06625814Phase 1
- A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016)CompletedNCT06619678Phase 1
- A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)CompletedNCT06619665Phase 1
- A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-003)CompletedNCT06619314Phase 1
- A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation in Healthy Adult Participants (MK-4482-011)CompletedNCT06615869Phase 1
- A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)CompletedNCT06611033Phase 1
- A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)CompletedNCT06609512Phase 1
- Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza ComplicationsCompletedNCT06609460Phase 2
- A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)CompletedNCT06609161Phase 1
- A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)CompletedNCT06597760Phase 1
- Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)Active, not recruitingNCT06596694Phase 1/2
- Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020)CompletedNCT06596668Phase 1
- A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)CompletedNCT06592339Phase 1
- A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)CompletedNCT06586671Phase 1
- A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)CompletedNCT06586606Phase 1
- A Study of MK-2060 in Healthy Participants (MK-2060-016)CompletedNCT06582602Phase 1
- A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)CompletedNCT06580587Phase 1
- A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009)CompletedNCT06575933Phase 1
- Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)CompletedNCT06575595Phase 1
- A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DMEActive, not recruitingNCT06571045Phase 2/3
- A Study of MK-6552 and the Effect of Food in Healthy Participants (MK-6552-006)TerminatedNCT06567002Phase 1
- A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)CompletedNCT06566989Phase 1
- MSD Belzutifan PASWithdrawnNCT06554730
- A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)CompletedNCT06554639Phase 1
- A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)Active, not recruitingNCT06504394Phase 2
- Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef ExtensionActive, not recruitingNCT06492291Phase 3
- A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)Active, not recruitingNCT06483334Phase 1/2
- A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)CompletedNCT06465186Phase 2
- A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)CompletedNCT06460961Phase 1
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)Active, not recruitingNCT06459180Phase 3
- Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)Active, not recruitingNCT06456346Phase 3
- A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)CompletedNCT06442436Phase 1
- Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)Active, not recruitingNCT06428396Phase 2
- A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)WithdrawnNCT06395090Phase 1/2
- A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)Active, not recruitingNCT06356311Phase 3